AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Many factors affect immunity to Streptococcus pneumoniae.

Vaccine Weekly

| August 13, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 AUG 13 - (NewsRx.com & NewsRx.net) -- The factors affecting production and efficacy of vaccines against Streptococcus pneumoniae are reviewed in the journal Current Opinion in Infectious Diseases.

According to recent research from Spain, "Streptococcus pneumoniae is a complex human pathogen and a major cause of morbidity and mortality. The genetic background of pneumococci and the chemical structure of their capsules are largely unraveled as well as the basic role of anticapsular antibodies and other opsonins interacting to enhance phagocytosis."

"Many experimental studies are improving our knowledge on the complex molecular mechanisms underlying those events," stated Julio Casal and David Tarrago at the Instituto de Salud Carlos III. "Pneumococcal optimal clearance requires the cooperation of a plethora of reactions from both innate and adaptive immunity."

"The last advances in the complexity of the immune response and protection are reviewed: phagocyte-pneumococcus interactions mediated by opsonins; the role of complement, reactive C protein, and natural antibodies; details of novel immune evasion mechanisms; the complex role of the inflammatory mediators in the susceptibility to pneumococcal infections; why capsular polysaccharides do not yield an anamnestic response after primary immunization; the central question of whether T ...

Related articles from newspapers, magazines, journals, and more
Many factors affect immunity to Streptococcus pneumoniae.
Newspaper article from: Biotech Week August 13, 2003 700+ words
...vaccines against Streptococcus pneumoniae are reviewed...the journal Current Opinion in Infectious...Spain, "Streptococcus pneumoniae is a complex...study in Current Opinion in Infectious...Immunity to Streptococcus pneumoniae: factors...
New York, California, Massachusetts Inventors Develop Isolated Streptococcus...
News wire article from: US Fed News Service, Including US State News July 31, 2008 700+ words
...have developed an isolated Streptococcus pneumoniae polynucleotide. According to...genomic nucleotide sequence of Streptococcus pneumoniae, wherein the open reading frames...that are surface localized on Streptococcus pneumoniae. Thus, the invention relates...
New Study Shows Ceftriaxone Remains Highly Active Against Streptococcus...
Press release article from: PR Newswire October 26, 2001 700+ words
...widely used antibiotics against Streptococcus pneumoniae in patients 65 years and older...Diseases Society of America. Streptococcus pneumoniae is the most commonly isolated...recent study examining bacteremic Streptococcus pneumoniae infection, the incidence of drug...
Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae...
Press release article from: PR Newswire April 7, 2009 700+ words
...Development of Intercell's Streptococcus pneumoniae vaccine supported by PATH VIENNA...disease caused by the bacterium Streptococcus pneumoniae has started. Intercell's vaccine...conserved surface proteins from Streptococcus pneumoniae. Two of these proteins were discovered...
Streptococcus pneumoniae-like organisms cause epidemic conjunctivitis.
Newspaper article from: TB & Outbreaks Week November 4, 2003 700+ words
...that nontypeable Streptococcus pneumoniae-like organisms...conjunctivitis as Streptococcus pneumoniae. According to...were confirmed as Streptococcus pneumoniae by DNA-DNA re...
BIOCHEM PHARMA AND BIOVECTOR THERAPEUTICS TO COLLABORATE ON STREPTOCOCCUS...
Press release article from: PR Newswire February 15, 2000 700+ words
...process of a nasal vaccine against Streptococcus pneumoniae that incorporates Biovector Therapeutics...for Biovector Therapeutics, as Streptococcus pneumoniae represents an unmet medical need...administration of vaccines.'' Streptococcus pneumoniae is a major cause of morbidity...
Streptococcus pneumoniae peptides enhance vaccine efficacy.
Newspaper article from: Health & Medicine Week August 18, 2003 700+ words
...with whole parent proteins of Streptococcus pneumoniae, according to a report in the...cell help for vaccination against Streptococcus pneumoniae (Pn) using self and foreign...carriers in a conjugate vaccine for Streptococcus pneumoniae: Self-heat shock protein 60...
FDA Approves Avelox(R) (moxifloxacin HCI) for Community Acquired Pneumonia Due...
Press release article from: PR Newswire May 19, 2004 700+ words
...caused by multi-drug resistant Streptococcus pneumoniae (MDRSP*). Avelox is the first...Acquired Pneumonia (CAP) caused by Streptococcus pneumoniae (including multi-drug resistant...Bronchitis (ABECB) caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA